NCT05848375

Brief Summary

Damage to the tendons of the shoulder, called rotator cuff, causes pain and loss of strength that may require surgery. This operation is performed under general anesthesia combined with loco-regional anesthesia of the shoulder. Indeed, this loco-regional anesthesia makes it possible to specifically suppress the sensation of pain in the shoulder for several hours after surgery. General anesthesia is produced by injecting drugs intravenously and breathing anesthetic vapors. Repair of the rotator cuff under loco-regional anesthesia alone is performed by several surgeons in France and is recommended by international experts. If blood pressure is artificially lowered during general anesthesia, loco-regional anesthesia alone allows maintenance of blood pressure and real-time clinical assessment since the patient is conscious. The purpose of the research is to compare the blood pressure measured during surgery of patients operated under loco-regional anesthesia alone or associated with general anesthesia, two common practices of surgical teams.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2023

Geographic Reach
1 country

4 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 21, 2023

Completed
17 days until next milestone

First Posted

Study publicly available on registry

May 8, 2023

Completed
6 months until next milestone

Study Start

First participant enrolled

November 13, 2023

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2025

Completed
Last Updated

June 13, 2024

Status Verified

June 1, 2024

Enrollment Period

1.1 years

First QC Date

April 21, 2023

Last Update Submit

June 12, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • compare systolic blood pressure (SBP) measured during surgery between patients operated for rotator cuff repair under LRA alone and those under LRA and GA.

    The main evaluation criterion is the average systolic pressures, measured in the supine position, before loco-regional anesthesia, in the induction room, then in the prone position on entering the operating room, then in a semi-sitting position, and every 5 minutes during the surgery, the duration of which varies according to the patient between 30 and 45 minutes. The average of the systolic blood pressures will be calculated on the available data, with a minimum of 4 values.

    Day 0

Secondary Outcomes (7)

  • Hydraulic pressure during surgery

    Day 0

  • The intensity of bleeding during surgery

    Day 0

  • Sedation administered to the patient during surgery

    Day 0

  • Patient pain after surgery

    Day 1 to day 21

  • Patient satisfaction 3 weeks after surgery

    3 weeks

  • +2 more secondary outcomes

Study Arms (2)

Loco regional anesthesia alone

EXPERIMENTAL

Arthroscopic rotator cuff repair performed under LRA alone

Procedure: Arthroscopic rotator cuff repairDrug: naropeine or chirocaine (Arthroscopic rotator cuff repair under LRA)

Loco regional anesthesia associated to general anesthesia

ACTIVE COMPARATOR

Arthroscopic rotator cuff repair performed under LRA and GA

Procedure: Arthroscopic rotator cuff repairDrug: naropeine or chirocaine (Arthroscopic rotator cuff repair under LRA associated to GA)

Interventions

The operation involves systematic acromioplasty during the supra +/- infraspinatus repair and sometimes requires a tenotomy of the long biceps if it is pathological.

Loco regional anesthesia aloneLoco regional anesthesia associated to general anesthesia

Loco Regional Anesthesia is performed by injecting anesthetic (between 10 and 20 ml of naropeine or chirocaine) into the interscalene nerve block under ultrasound guidance associated to General Anesthesia performed by injection of diprivan and ultiva.

Loco regional anesthesia associated to general anesthesia

Loco Regional Anesthesia is performed by injecting anesthetic (between 10 and 20 ml of naropeine or chirocaine) into the interscalene nerve block under ultrasound guidance

Loco regional anesthesia alone

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient, male or female, aged 18 and over
  • Patient with a supraspinatus lesion or supraspinatus and infraspinatus lesions requiring surgery for arthroscopic rotator cuff repair, with a non-retracted or minimally retracted tendon (lower stage or = 2 according to the Patte score) and a muscle with little or no fat infiltration (fatty infiltration less than or = 2 according to the Goutallier classification)
  • Affiliated participant or beneficiary of a social security scheme.

You may not qualify if:

  • Patient with a history of surgery for the operated shoulder
  • Patient with stage \>1 glenohumeral osteoarthritis according to the Samilson classification
  • Patient requiring associated subscapularis repair
  • Patient with a contraindication to LRA or a contraindication to GA
  • Patient wishing a type of anesthesia
  • Patient with a contraindication to day surgery
  • Patient with neuropathy
  • Patients with a history of vagal, emotional or stress-prone discomfort
  • Participant whose physical and/or psychological health is severely impaired, which according to the investigator may affect the participant's compliance with the study.
  • Patients participating in another research
  • Protected participant: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision.
  • Pregnant, breastfeeding or parturient woman.
  • Participant hospitalized without consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Clinique Bretéché

Nantes, 44000, France

RECRUITING

CHP St Grégoire

Saint-Grégoire, 35760, France

NOT YET RECRUITING

Clinique Belledonne

Saint-Martin-d'Hères, France

RECRUITING

Hôpital privé St Claude

Saint-Quentin, France

RECRUITING

MeSH Terms

Interventions

RopivacaineLevobupivacaine

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAminesBupivacaine

Study Officials

  • Laurent BAVEREL, Dr

    Clinique Bretéché ELSAN

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Vincent WYART, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Interventional study, randomized in two parallel groups, multicenter (trial of superiority) : The research procedure for arthroscopic rotator cuff repair is performed under local regional anesthesia alone without general anesthesia. LRA is performed by injecting anesthetic into the interscalene nerve block under ultrasound guidance. This LRA can be accompanied by hypnotic or morphine sedation. The comparison procedure is arthroscopic rotator cuff repair performed under LRA and GA
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 21, 2023

First Posted

May 8, 2023

Study Start

November 13, 2023

Primary Completion

December 1, 2024

Study Completion

July 1, 2025

Last Updated

June 13, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations